Circulating miR-1 as a potential biomarker of doxorubicin-induced cardiotoxicity in breast cancer patients.
Rigaud VO, Ferreira LR, Ayub-Ferreira SM, Ávila MS, Brandão SM, Cruz FD, Santos MH, Cruz CB, Alves MS, Issa VS, Guimarães GV, Cunha-Neto E, Bocchi EA.
Rigaud VO, et al.
Oncotarget. 2017 Jan 24;8(4):6994-7002. doi: 10.18632/oncotarget.14355.
Oncotarget. 2017.
PMID: 28052002
Free PMC article.